4
Changes in Ownership
Eledon Pharmaceuticals, Inc. Filed Acc 0000899243-17-012816
Director acquired 2,537,110 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| OrbiMed Israel GP Ltd. Director | 2017-05-09 | Grant or award | +2,537,110 | 2,537,110 | I: show line 1 in the form |
Loading xslF345X03/doc4.xml…